2014 Continuing Compliance Master Series Interim Self-Inspection: What is it and How to do it John D. Olson, MD, PhD, FCAP March 19, 2014 www.cap.org Today’ss Presenter - John D. Today D Olson, Olson MD, MD PhD Dr. John Olson graduated from the University of Colorado and received his Medical Degree from Georgetown University. Following his residency at the Mayo Clinic he received his PhD degree from the University of Minnesota. He is currently Professor and Vi Vice Ch Chair i for f Clinical Cli i l Affairs Aff i in i the th Department D t t off Pathology at the University of Texas Health Science Center in San Antonio and is the Director of the Clinical Laboratories for the South Texas Reference Laboratories. Dr. Olson served on the CAP Coagulation Resource Committee from 1993-2004, serving as its chair 19992004. He is currently a member for the Continuous Compliance Committee Committee. Dr Dr. Olson Olson’ss academic career has focused on issues of hemostasis and thrombosis. He also has interest in quality management in the laboratory. © 2014 College of American Pathologists. All rights reserved. 2 Learning Objectives A a result As lt off participating ti i ti iin thi this activity, ti it you will ill be b able bl to: t o Explain the importance of the interim self-inspection o Apply pp y best p practices to y your interim self-inspection p o Describe how the interim self-inspection will help prepare you for an unannounced on-site inspection o Describe how the interim self-inspection self inspection will help improve laboratory quality and promote continuous compliance with accreditation requirements. © 2014 College of American Pathologists. All rights reserved. 3 Purpose of the Self Self-Inspection Inspection • Ongoing compliance with the Standards • Update p laboratory yp practice to comply p y with current checklist requirements • Prepare for the next on-site inspection • Laboratory improvement and better patient care © 2014 College of American Pathologists. All rights reserved. 4 GEN 23584: Interim Self GEN.23584: Self-Inspection Inspection • Th The laboratory l b t conducts d t an interim i t i self-inspection lf i ti and documents efforts to correct deficiencies g that p process. identified during © 2014 College of American Pathologists. All rights reserved. 5 GEN 23584 (Continued) GEN.23584 • NOTE: The interim self-inspection is an important aspect of continuing education and laboratory improvement. improvement The use of a variety of mechanisms for self-inspection (residents, technologists or other inspectors) is strongly endorsed. Self inspection by personnel familiar with, but not directly involved in, the routine operation of the l b laboratory t section ti to t b be iinspected t d iis a b bestt practice. ti Documentation of performance of the interim self-inspection with correction of deficiencies is a requirement for maintaining y must document that p personnel accreditation. The laboratory responsible for each laboratory section have reviewed the findings of the interim self-inspection. • Evidence of Compliance: • Written evidence of self-inspection findings with records of corrective action © 2014 College of American Pathologists. All rights reserved. 6 Get a Fresh Look at Your Operations Use the interim self-inspection to look at your laboratory or have someone else look at your laboratory as if seeing it for the first time. © 2014 College of American Pathologists. All rights reserved. 7 Let’ss Get Organized Let Plan for completion p before y your Self-inspection p Verification Form is due to be returned to the CAP: 1. Identify a Team Leader for your self-inspection process ((t-60 days) p y) 2. The team leader will identify inspectors to perform the self-inspection (t-45 days) 3 Perform inspection (t-30 3. (t 30 to t-15 t 15 days) 4. Team meets to review findings 5. Summation Conference (t-7 days) 6. Mail self-inspection confirmation to CAP (t-7 to t-1 days) 7 Corrective action and documentation (t+30 days) 7. © 2014 College of American Pathologists. All rights reserved. 8 Team Leader • Someone with experience p with the inspection p process • Has p previously y been a team leader or member of a team inspecting another laboratory • Has taken the Team Leader Training g offered online at CAP.org: http://learning.cap.org/catalog/options/view/c cf50d5a 9a33 438a 8872 469831d6194f cf50d5a-9a33-438a-8872-469831d6194f • An opportunity to lead a project © 2014 College of American Pathologists. All rights reserved. 9 Self-Inspection Self Inspection Team Members • Use supervisory staff, experienced non-supervisory technical staff, residents, fellows • Cross discipline lines when practical - Cultivates new team members for future inspections - Provides depth for unannounced on-site inspections - Prepares staff for inspection interviews - Elucidates weaknesses • Explore exchange with other laboratories in your region • All team members should take the inspector training at CAP.org: http://learning.cap.org/catalog/options/view/d9c451f3 -addd-4d09-b24a-5b1f83d27a3e © 2014 College of American Pathologists. All rights reserved. 10 Initial Team Leader Meeting with Inspectors 1. Assignments and distribution of checklists - Have the checklists provided for the inspection - Be clear about the assignments for each team member - Define any focus issues 2. Establish timing - Timing is flexible so set precise goals - Lay out the entire timeline 3. Define communication and “esprit de corps” - New members will have questions. Provide them support - Collegial process, inspector and laboratory are both learning © 2014 College of American Pathologists. All rights reserved. 11 Inspection Process • Focus Issues o Prior inspection deficiencies, on site or self-inspection − There is no reason for and there should not be recurrence of prior deficiencies o Known issues in your laboratory (products of your event management program) − Many of the events that occur in the laboratory are related to accreditation requirements − Check that all events have documented corrective action; verify that you are compliant for accreditation © 2014 College of American Pathologists. All rights reserved. 12 Inspection Process • Focus Issues o Common problems (deficiencies) found in inspections of other laboratories - We will review some common issues that are found during g inspections p g generally. y - Data is a compilation of the findings of all CAP inspections. © 2014 College of American Pathologists. All rights reserved. 13 Inspection Process • 2012: Common Deficiencies o Among the checklist items, many laboratories are cited for the same issues o Comparing the current list of common d fi i deficiencies i tto th those off prior i years, we find fi d that the most frequently cited deficiencies are similar from one year to the next, and do not necessarily involve new requirements © 2014 College of American Pathologists. All rights reserved. 14 Inspection Process Most Common Deficiencies in 2012 GEN.55500 Competency Assessment GEN.20375 Document Control System GEN.75400 Annual Fire Drill COM.01700 Proficiency Testing (PT) Evaluation COM.10000 Complete Procedure Manual COM 01400 PT Attestation COM.01400 Att t ti Statement St t t CHM.10100 Procedure Review POC.06900 Competency Assessment CHM 13600 AMR Validation CHM.13600 V lid ti COM.10300 Knowledge of Procedures 0 100 © 2014 College of American Pathologists. All rights reserved. 200 300 400 500 600 15 Inspection Process Five Phase II Items Most Often Cited from the All Common Checklist: o COM.01100 Laboratory has procedure for grading g intended to be graded, g , but which were challenges not o COM.01500 Alternative Assessment o COM.01600 Proficiency Testing Integration into Routine Workload o COM.01700 Proficiency Testing & alternative assessment: evaluation and corrective action o COM.10100 Procedure Manual Review had been annual now at least every two years annual, © 2014 College of American Pathologists. All rights reserved. 16 Polling Question 1 While performing your self inspection, you are asked to review the Proficiency Testing records. records You find that your Director has correctly signed every attestation sheet for the past 2 years except for the A mailing of the CGL survey this year. year What do you do? A Cite a Phase II deficiency for failure to sign the A. attestation. B. Issue a recommendation the laboratory has established practice of signing. C. This is minor, cite yourself for only a Phase I deficiency. © 2014 College of American Pathologists. All rights reserved. 17 Inspection Process Most Cited Discipline Specific Deficiencies in 2012 POC.06900 Competency Assessment CHM.13600 C 3600 Validation of Analytic y Measurement Range g TLC.11425 Delegation of Director Duties CHM.13800 Method Comparisons MIC.11020 Quality y Control Monthly y Review POC.07300 Daily Control Testing TRM.31450 Method Comparisons HEM.24000 Reagent g Labeling g ANP.12087 Cryostat Decontamination ANP.08216 Formaldehyde Monitoring 0 100 © 2014 College of American Pathologists. All rights reserved. 200 300 400 500 600 18 Inspection Process CHM.13600 (Phase II) Validation of the analytical measurementt range (AMR) is i performed f d with ith matrixti appropriate materials which include the low, mid and high range of the AMR, appropriate acceptance criteria are defined, d fi d and d th the process is i documented. d t d Common reasons for citations: o Did nott revalidate lid t every 6 months th o Did not include materials than span the assay range o Did not include all applicable analytes in the validation process (e.g. blood gases, BNP, and TNI) o New issue in Hemostasis that is generating questions © 2014 College of American Pathologists. All rights reserved. 19 Inspection Process TLC.11425 (Phase II) If the laboratory director has delegated some functions to others others, documentation specifies the individuals and the specific activities so authorized. Common reasons for citations: o No documentation o Duties or individuals not included o Delegated activities that must not be delegated such as new procedure or policy review o Letter/memo needs to be specific regarding the duties that are being delegated © 2014 College of American Pathologists. All rights reserved. 20 Inspection Process CHM.13800 (Phase II) If the laboratory uses more th than one instrument/method i t t/ th d to t test t t for f a given i analyte, the instruments/methods are checked against g each other at least twice a y year for correlation of results. Common reasons for citations: o Not performed twice per year o Not including all the appropriate instruments/methods o No established criteria for acceptability o Also Al TRM TRM.31450 31450 (Ph (Phase II) © 2014 College of American Pathologists. All rights reserved. 21 Inspection Process MIC.11020 MIC 11020 (Phase II) Quality control data are reviewed and assessed at least monthly by the laboratory director or designee. Common reasons for citation: o No documentation o Not completed monthly o Not performed by a documented designee o Also POC.07300 Managing controls for POCT © 2014 College of American Pathologists. All rights reserved. 22 Inspection Process ANP.23410 (Phase II) There is a documented procedure for the routine decontamination of the cryostat at defined intervals, and decontamination records are evident. Common reasons for citations: o Lack of documentation o Laboratories sometimes use uv or fog, but do not physically wipe the cryostat down o LLaboratories b t i aren’t ’t using i the th cryostat t t daily d il and d are unsure of the frequency of decontamination o Laboratories have a difficult time decontaminating once per week due to high volumes and only one cryostat available. © 2014 College of American Pathologists. All rights reserved. 23 Inspection Process ANP.08216 (Phase II) Formaldehyde and xylene vapor concentrations are maintained below the f following i maxima, i expressed as parts per million, i i in i all areas of the Anatomic Pathology Department where formaldehyde or xylene are used. Common Reasons for Citations: • Laboratories sometimes don don’tt do both the 15 minute and the 8 hour monitoring • Laboratories have small quantities of these chemicals and believe that the requirement does not apply to them. them • Do not repeat the monitor when changes have taken place in the laboratory that could potentially increase exposure such as changes h in i production, d ti equipment, i t personnell © 2014 College of American Pathologists. All rights reserved. 24 Polling Question 2 While performing your self inspection you find a procedure was l t reviewed last i d and d signed i d 18 months th previously. i l Your Y laboratory’s l b t ’ quality plan states that procedures are reviewed annually. you do? What do y A. Current CAP regulations require review every 24 months so this is compliant. e laboratory’s abo a o y s policy po cy sstates a es the e review e e iss to o be every e e y 12 B.. The months. This is a Phase II deficiency. C. The laboratory’s policy states the review is to be every 12 months. Write a recommendation to update the policy. © 2014 College of American Pathologists. All rights reserved. 25 Inspection Process Encourage g inspectors p to: o Spend time in the laboratory! o Interview non-supervisory staff (bench techs, phlebotomists, hl b t i t order d entry t personnel) l) − Structure the interim self-inspection to be as similar to the on on-site site inspection as possible: − Interview non-supervisory personnel during th self the lf inspection i ti -- does d everyone know k the policies as well as the supervisors? © 2014 College of American Pathologists. All rights reserved. 26 Inspection Process Testing Readiness o “If your supervisor were not here on the day of the inspection, p how would y you respond p if y you were asked by the inspector…” − …for a certain procedure or practice? − …where PT policies are located? − …where the Chemical Hygiene plan is housed? − …where where the maintenance records are kept? − …etc. © 2014 College of American Pathologists. All rights reserved. 27 Inspection Process • An Example: p What’s the p problem? • GEN.41067 (Phase II) • No written policy. • “D “Does th the LLaboratory b t director review the format of the report p on a bi-annual basis?” • N No documentation d t ti that this is occurring. • I look at report formats every day! © 2014 College of American Pathologists. All rights reserved. 28 Inspection Process The Lesson: • Provide documentation that th activity the ti it is i being b i performed. • “If If you didn didn’tt write it down, it did ’t didn’t happen……” • Failure to document equals non noncompliance. © 2014 College of American Pathologists. All rights reserved. 29 Inspection Process Famous Last Words “Oh yes, we do all of that all of the time!” Dr. I. M. Complacent, p Medical Director Mediocre Laboratories, USA When you are in Wh i a familiar f ili environment, i t same place l and d activity, ti it day after day, you can overlook details, forget best practices and become complacent. Consistency is also an issue. Do all of the staff perform the same procedures the same way. © 2014 College of American Pathologists. All rights reserved. 30 Inspection Process Safety y o Safety procedures and policies posted readily available to all employees? o Documentation of safety training to new employees. o During the Interim Self-Inspection, Self Inspection interview personnel regarding contents of the safety manual. − Choose several items to ask non-supervisory staff. © 2014 College of American Pathologists. All rights reserved. 31 Inspection Process Competency Assessment o During D i th the fi firstt year off patient ti t ttesting, ti competency assessment must be performed every six months. o Competency must be reassessed at least annually. o Confirm all six elements are included for each test system (if applicable). o Managing Competency for POCT is a problem i many iinstitutions. in tit ti o PPMP now requires competency with the same detail as others who p perform testing. g © 2014 College of American Pathologists. All rights reserved. 32 Inspection Process Point of Care Testing g o Inspection of POCT requires the use of the POCT checklist and all applicable portions of the L b Laboratory t General G l checklist. h kli t o For accreditation, all analytes being measured under the program/site are included in the live CAP inspection. o POCT is often overlooked in the self-inspection. o Not in the Laboratory, but the Laboratory provides oversight. Be sure all elements are compliant compliant. © 2014 College of American Pathologists. All rights reserved. 33 Inspection Process (GEN.20375) Elements of Document Control System • Policies, procedures and processes (P/P/P) current • Personnel have read the relevant documents • P/P/P have been authorized by the director • P/P/P reviewed annually by the director or designee • Discontinued P/P/P are archived and quarantined a in separate file • Are all required elements present? Are Documents current? © 2014 College of American Pathologists. All rights reserved. 34 Polling Question 3 Your laboratory has a new director. She started as the director just a month ago. As you review the procedures, you o note that onl only one ne new major re revision ision has occurred occ rred that she has signed. All other procedures have been signed by the prior director. What do you do? A. The new director must only sign the new procedures from her start date, not prior procedures. B. Cite a Phase II deficiency. The new director is required to approve and sign ALL procedures. g all procedures p but is allowed a C. The director must sign “reasonable time” to complete the task. © 2014 College of American Pathologists. All rights reserved. 35 Inspection Process Team Leader Assessment of the Laboratory Director and Quality Checklist • Evaluate the qualifications of the Laboratory Director. • Assess the effectiveness with which that individual implements and supports the Standards of the Laboratory Accreditation Program. • C Conduct d t th the iinterview, t i it can help h l provide id d depth th for the on-site inspection. © 2014 College of American Pathologists. All rights reserved. 36 Inspection Process Team Leader Assessment of the Laboratory Director and Q lit Checklist Quality Ch kli t • Review documents: o QM plan -- include review of specific monitors, corrective actions. o Organizational chart -- does it represent operations? • H Has th there been b a change h in i the th Laboratory L b t Director? Di t ? o COM.10400: If there is a change in laboratory directorship, the new laboratory director reviews and approves (over a reasonable period of time) that laboratory procedures are current. − Create your own goals, write them down and document docu e that a you a are ep progressing. og ess g. © 2014 College of American Pathologists. All rights reserved. 37 Inspection Process Quality Management • Your event management g program p g drives much of your quality management g selection of indicators • Thoughtful • Corrective actions documented • Director’s Di t ’ iinvolvement l t iin d development l t and d management of Quality © 2014 College of American Pathologists. All rights reserved. 38 Inspection Process Review of Proficiency Testing • Variant Proficiency Testing performance report • “Drill down” troublesome analytes • Alternative Assessment • Do not share or refer Proficiency Testing results! © 2014 College of American Pathologists. All rights reserved. 39 Inspection Process Patient Safety y Policy y • Rigorous adherence to patient identification p procedures • Reporting of life threatening conditions/ critical values • Strategies for preventing medical errors • Institutional approach © 2014 College of American Pathologists. All rights reserved. 40 Inspection Process H dli Handling off C Complaints l i t • Honestly review the culture of your laboratory. • Do a policy and procedure exist? • Do the policy and procedure match actual practice? © 2014 College of American Pathologists. All rights reserved. 41 Team Meeting at Completion of Inspection • Review all deficiencies identified during the inspection o Common issues may arise o Discuss any y issues about which an inspector p may y be uncertain • O Organize g the summation conference © 2014 College of American Pathologists. All rights reserved. 42 Summation Conference • Hold a formal summation conference • Invite the leadership of the organization p Administration, Director of Organization, g o Hospital Quality o Your opportunity to shine • Identify the strengths and quality of the laboratory • Review the opportunities for improvement that have been identified o All inspectors or just the team leader • Open and Close on a positive note © 2014 College of American Pathologists. All rights reserved. 43 Paperwork • Send to the CAP: o Self Self-inspection inspection Verification Form − Signed by Director © 2014 College of American Pathologists. All rights reserved. 44 Corrective Actions • Plan corrective action for all cited deficiencies • Collect documentation that the corrective action has addressed the problem p • Complete these tasks within ? days, fix the time frame • File the information for review by the next on-site inspection team • In 6 months, pull the file and document that the corrective actions have been successful © 2014 College of American Pathologists. All rights reserved. 45 Inspector Summation Report: Five Crucial Questions At your on-site inspection, the inspection team leader with ith write it a reportt iincluding l di th the ffollowing ll i elements. l t Consider these same elements as you conclude the self-inspection process: 1. Does the laboratory meet the standards? 2. Is the Director qualified? 3. If no, is there a qualified supervisor for each section? 4. Is administration satisfied? 5 Is the medical staff satisfied? 5. © 2014 College of American Pathologists. All rights reserved. 46 What Inspectors Will Focus on About Your SelfInspection • IInspectors t h have b been instructed i t t d tto review i the th results of the interim self-inspection o Request list of cited deficiencies and scrutinize documentation of corrective action • Probing questions will be asked about the self selfinspection o How seriously did the laboratory take the process? o Were genuine concerns detected and corrected? © 2014 College of American Pathologists. All rights reserved. 47 Summary of Best Practices • Involve multiple p staff members in the self-inspection p • Make this a formal event for your laboratory • Look at y your laboratory y as if y you are seeing g it for the first time • Ask questions of the bench technologists and other staff t ff • Hold a summation conference encouraging all who are able to attend • Document corrective action for all deficiencies cited © 2014 College of American Pathologists. All rights reserved. 48 The Interim Self Self-Inspection Inspection – The Bottom Line The laboratory y is required q to p perform the interim selfinspection, but don’t do the inspection because it is required, do it because it will help you maintain and improve the quality of your laboratory. laboratory Sustaining continuous compliance with the accreditation standards is a challenge for Laboratories regardless of size i and d complexity l it and d requires i a robust b t quality lit program. The inspection process is an important g part p of that p program g and, when p performed integral well, helps the continuous improvement of the Laboratory. © 2014 College of American Pathologists. All rights reserved. 49 Acknowledgements/Thank You • Thanks to Dr. Renee Ellerbroek and Dr. Earle Collum • Thanks to Continuous Compliance Committee members, Accreditation Education Committee members, Suzan Mraibie, Jean Ball, Rodney Stewart and other CAP staff for assistance in preparing this presentation. presentation • Thank you to our participants for their time. Keep in mind the tool kit is available with the link your site coordinator has received © 2014 College of American Pathologists. All rights reserved. 50 Questions © 2014 College of American Pathologists. All rights reserved. 51 Technical Assistance http://www.cap.org Email: [email protected] p g 800 323 4040 ext. 800-323-4040, t 6065 © 2014 College of American Pathologists. All rights reserved. 52 53
© Copyright 2025